Skip to content

Clinical trials

Completed Phase 2 Cognition Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognition Disorders Phase: Phase 2 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20064
20071
20091
20102
20122
20131
20141
20161
20181
20201
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pennsylvania2
University of Washington2
Wake Forest University Health Sciences2
Antonia New1
AstraZeneca1
Brain and Cognition Discovery Foundation1
Cerecin1
Cognition Pharmaceuticals, LLC1
Duke University1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognition Disorders22
Cognitive Dysfunction10
Fatigue3
HIV Infections3
Mental Disorders3
Schizophrenia3
AIDS-Related Complex2
Acquired Immunodeficiency Syndrome2
Alzheimer Disease2
Delirium2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.